Xuewei Wang

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Fei Liu, W. Jia, Xiaoming Yang, 2022, bioRxiv.

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.

Yongli Yang, A. Pan, S. Shen, 2020, JAMA.

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

Xinxin Zhang, Xiaoming Yang, Yunkai Yang, 2022, Frontiers of Medicine.

COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan

Dong Liu, Jiayou Zhang, Junzheng Wu, 2022, Cell discovery.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial

A. Pan, S. Shen, Xiaoming Yang, 2021, EClinicalMedicine.

Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.

Wangxue Chen, S. Logan, J. Chen, 2020, Vaccine.

Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.

Wangxue Chen, J. Chen, Y. Zhong, 2020, Microbial pathogenesis.